logo

GANX

Gain Therapeutics·NASDAQ
--
--(--)
--
--(--)

GANX fundamentals

Gain Therapeutics (GANX) released its earnings on Aug 12, 2025: revenue was 0 (YoY --), met estimates; EPS was -0.19 (YoY +54.76%), missed estimates.
Revenue / YoY
0
--
EPS / YoY
-0.19
+54.76%
Report date
Aug 12, 2025
Earnings Call
4:00 PM on Aug 14, 2025
Meeting link.

Earnings

EPS
Revenue

Revenue & Expenses

Key Indicators

Gain Therapeutics (GANX) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Gain Therapeutics (GANX)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown

Balance Sheet

Gain Therapeutics (GANX)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown

Cash Flow

Gain Therapeutics (GANX)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown

Revenue Breakdown

Where does Gain Therapeutics (GANX) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:

Dividend

Track Gain Therapeutics (GANX) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield